Journal Article

Rapid Resolution of <i>Mycobacterium marinum</i> Chronic Skin Infection during Lenalidomide Therapy for Chronic Lymphocytic Leukemia

Ahmed Awais, Constantine S. Tam, Dimitrios Kontoyiannis, Alessandra Ferrajoli, Madeleine Duvic, Jorge Cortes and Michael J. Keating

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 46, issue 7, pages e69-e71
Published in print April 2008 | ISSN: 1058-4838
Published online April 2008 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1086/529388
Rapid Resolution of Mycobacterium marinum Chronic Skin Infection during Lenalidomide Therapy for Chronic Lymphocytic Leukemia

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

The immunomodulatory drug lenalidomide is currently being evaluated for its antineoplastic properties in treating hematologic malignancies. However, its potential role in augmenting immune reactions against opportunistic infections has not been explored. We report the rapid resolution of chronic Mycobacterium marinum infection in a patient following initiation of lenalidomide therapy for chronic lymphocytic leukemia.

Journal Article.  1277 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.